Oesophago-gastric adenocarcinoma: understanding disease pathogenesis and applications to earlier diagnosis

A simple cell-sampling device called the Cytosponge, swallowed in a GP surgery like a large pill, could replace endoscopy for spotting early signs of oesophageal cancer. Oesophageal cancer is rising rapidly in the Western world and is often fatal unless caught early. Current diagnosis relies on endoscopy—an invasive, expensive procedure that is impractical for widespread screening. This research aims to understand how the cancer develops and to translate that knowledge into a practical, non-invasive test. The Cytosponge collects cells from the gullet, which are then analysed in the lab for specific protein and gene alterations that signal precancerous changes. If successful, the Cytosponge could transform oesophageal cancer diagnosis from a hospital-based procedure into a routine GP appointment. This would allow far more people to be screened, catch the disease at a treatable stage, and ultimately reduce deaths. The test is now being developed for routine clinical use, moving from the research lab toward the clinic.